ARCT
ARCT
NASDAQ · Biotechnology

Arcturus Therapeutics Holdin

$8.31
-0.05 (-0.60%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 16 84%
Hold 3 16%
Sell 0 0%
Price Target
Analyst Price Target +217.8% upside
Low Target $16.23
Average Target $26.41
High Target $33.18
Current Price $8.31
Current
$8.31
Target
$26.41
$16.23 $26.41 avg $33.18
Scenario Analysis
Bear Case
$16.23
95.3%
Low target
Base Case
$26.41
+217.8%
Avg target
Bull Case
$33.18
+299.3%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$17.96
-53.7% from high
52-Week Low
$5.50
+51.1% from low
Target vs 52W High
$26.41
+47.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.2%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +114.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -17.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
MRNA
Moderna Inc
Hold 31 32% $149.45 -30.6%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -50.5%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -31.6%